About Shelley Hartman
Shelley Hartman is CEO and director at Aegle Therapeutics.
Shelley Hartman first appears on SEC filings in 2020.
Experience
This experience comes from Shelley Hartman's profile and from SEC filings. For roles taken from filings, the years are when the filings name Shelley Hartman in the role, so the role may have started earlier or lasted longer.
Aegle Therapeutics Corp Current
Chief Executive Officer, Co-Founder (2014 – Present)
Director
2014 – Present · Woburn, MA
Develops cell-free therapies for people with rare and severe skin diseases.
UM
University of Miami, Miller School of Medicine
Entrepreneur in Residence
2014 – 2017
LI
LifeSync Holdings, Inc.
Chairman and CEO (2004 – 2016)
President, 2006-2012; Board Member, 2004-2013 (2004 – 2013)
2004 – 2016
GC
Goldman, Sachs & Co.
Managing Director
1994 – 2004
FB
First Boston
Vice President
1986 – 1994
Key Colleagues at Startups
The people Shelley Hartman works with at each company, as listed on that company's latest Form D.
Aegle Therapeutics Corp · Form D, Aug 28, 2026
Evangelos Badiavas
Inventor, Founder, Chief Scientific Officer and director
SB
Scott Braunstein
Chairman
LM
Leon Moulder
Director